Caspian Therapeutics: Funding, Investors & Team (Nov 2026)
Caspian Therapeutics is a biotechnology company developing menin inhibitors to treat diabetes.
Caspian Therapeutics has raised $50.0M across 1 funding round on record, the most recent a Seed of $50.0M announced in Sep 2026.
That round is above the $7.8M median round size for United States companies tracked on FundedIQ over the last two years.
Caspian Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Caspian Therapeutics Funding Rounds
Caspian Therapeutics Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
Caspian Therapeutics Funding in Context
Caspian Therapeutics' latest round of $50.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Caspian Therapeutics in Biotechnology and San Diego
Companies Similar to Caspian Therapeutics
Anaheim Bio develops small molecule therapies to treat calcium pyrophosphate deposition disease (CPPD) at its…
Genta Kyushu Bio develops precision neuro circuit therapies for CNS and eye diseases via optogenetics and…
Zipline designs, manufactures, and operates drones to deliver vital medical products.
Numica provides accounting and tax services for companies and individuals.
Firmly.ai is agentic commerce platform enabling seamless product discovery and checkout across AI and digital…
Arena applies predictive analytics and machine learning to talent acquisition challenges.
Synopsis is an AI driven tech company that offers data integration services.
Siggy is an AI-powered mental healthcare platform that combines digital therapy support, psychiatric…
Nyquis is an AI-powered grid protection platform that detects electrical faults in real time to prevent…
Sanaren builds human-centered technologies and compassionate digital solutions designed to support active…
Varda is a startup company in the field of space manufacturing that specializes in producing products in…
Shield AI is an artificial intelligence company that serves the national security sector. The company was…
Caspian Therapeutics Funding FAQs
What does Caspian Therapeutics do?
Caspian Therapeutics is a biotechnology company developing menin inhibitors to treat diabetes.
How much funding has Caspian Therapeutics raised?
Caspian Therapeutics has raised $50.0M across 1 round on record. The most recent is a Seed of $50.0M announced in Sep 2026.
When did Caspian Therapeutics last raise funding?
Caspian Therapeutics' most recent funding round on record is a Seed of $50.0M, announced in Sep 2026.
Who has invested in Caspian Therapeutics?
Investors on record for Caspian Therapeutics include Montanova Capital, Eli Lilly, Invus, Kura Oncology, Biotechnology Value Fund. FundedIQ records 6 investors in total.
Where is Caspian Therapeutics headquartered?
Caspian Therapeutics is based in San Diego, United States.
When was Caspian Therapeutics founded?
Caspian Therapeutics was founded in 2026.
About FundedIQ's Caspian Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Caspian Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.